Company intelligence / Profile preview

DrugTimes BD team

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

DrugTimes is a prominent media and business development service platform dedicated to the pharmaceutical and biotechnology sectors, with a primary focus on the Chinese market and its global connections. The organization serves as a strategic bridge for life science companies, offering services such as industry news reporting, professional networking, and business development consulting. Its specialized BD team actively facilitates cross-border licensing, partnerships, and investment opportunities by connecting drug developers with potential collaborators. Additionally, DrugTimes hosts significant industry conferences, webinars, and digital forums to promote innovation and knowledge sharing within the drug discovery and development community.

Industry: Consulting

Beyond the preview

Go deeper on DrugTimes BD team.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DrugTimes BD team.

Explore the full profile